Image

A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation.

Investigational Study for Pancreatic Cancer and Solid Tumors with KRAS p.G12C Mutation

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic cancer and other solid tumors with the KRAS p.G12C mutation. It includes patients who have progressed after previous treatments or are intolerant to them.

The study evaluates the effectiveness and safety of the investigational medication in treating these conditions. It focuses on understanding how well patients respond to the treatment.

  • Who can participate: Adult patients with the KRAS p.G12C mutation can participate. They must have advanced solid tumors, excluding NSCLC and CRC, and have progressed after prior therapies or are intolerant to them.
  • Study details: Participants will receive the investigational medication.
Print
Study details
    KRAS P.G12C
    Pancreatic Cancer
    Solid Tumor

NCT06008288

Allist Pharmaceuticals, Inc.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.